Viral vectors for gene delivery and gene therapy within the endocrine system

Journal of Endocrinology

Volumn 164, Issue 2, 2000, Pages 103-118

  Stone, D ^a   David, A ^a   Bolognani, F ^a   Lowenstein, P R ^a   Castro, M G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VECTOR;

ADENOVIRUS; ENDOCRINE DISEASE; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; TARGET CELL; VIRUS GENOME;

EID: 0034089010     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1640103     Document Type: Review

References (158)

1. Albarracin CT, Frosch MP & Chin WW 1999 The gonadotropin-releasing hormone receptor gene promoter directs pituitary-specific oncogene expression in transgenic mice, Endocrinology 140 2415-2421.
2. Becker TC, BeltrandelRio H, Noel RJ, Johnson JH & Newgard CB 1994 Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. Journal of Biological Chemistry 269 21234-21238.
3. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL & Finberg RW 1997 Isolation of a common receptor for Coxsackie B viruses and Adenoviruses 2 and 5. Science 275 1320-1323.
4. Bett AJ, Haddara W, Prevec L & Graham FL 1994 An efficient and flexible system for construction of adenovirus vectors with insertions or deletions m early regions 1 and 3. Proceedings of the National Academy of Sciences of the USA 91 8802-8806.
5. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A & McCormick F 1996 An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274 373-376.
6. Blomer U, Naldini L, Kafri T, Trono D, Verma IM & Gage FH 1997 Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. Journal of Virology 71 6641-6649.
7. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG & Mavilio F 1995 Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270 470-475.
8. Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO & Chiocca EA 1994 Long-term survival of rats harbouring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Research 54 5745-5751.
9. Braiden V, Nagayama Y, Iitaka M, Namba H, Niwa M & Yamashita S 1998 Retrovirus-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter. Endocrinology 139 3996-3999.
10. Brough DE , Lizonova A, Hsu C, Kulesa VA & Kovesdi I 1996 A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. Journal of Virology 70 6497-6501.
11. Byrnes AP, Rusby JE, Wood MJ & Charlton HM 1995 Adenovirus gene transfer causes inflammation in the brain. Neoroscience 66 1015-2104.
12. Byrnes AP, MacLaren RE & Charlton HM 1996 lmmunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. Journal of Neuroscience 16 3045-3055.
13. Canaff L, Bevan S, Wheeler DG, Mouland AJ, Rehfuss RP, White JH & Hendy GN 1998 Analysis of molecular mechanisms controlling neuroendocrine cell specific transcription of the chromogranin A gene. Endocrinology 139 1184-1196.
14. Carpenter DE & Stevens JG 1996 Long-term expression of a foreign gene from a unique position in the latent herpes simplex virus genome. Human Gene Therapy 7 1447-1454.
15. Cartmell T, Southgate T, Rees GS, Castro MG, Lowenstein PR & Luheshi GN 1999 Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. Journal of Neoroscience 19 1517-1523.
16. Castro MG 1999 Gene therapy strategies for the treatment of pituitary tumours. Journal of Molecular Endocrinology 22 9-18.
17. Castro MG, Goya RG, Sosa YE, Rowe J, Larregina A, Morelli A & Lowenstein PR 1997 Expression of transgenes in normal and neoplastic anterior pituitary cells using recombinant adenoviruses: long term expression, cell cycle dependency, and effects on hormone secretion. Endocrinology 138 2184-2194.
18. Castro MG, Windeatt S, Smith-Arica J & Lowenstein PR 1999a Cell-type specific expression in the pituitary: physiology and gene therapy. Biochemical Society Transactions 27 858-863.
19. Castro MG, Windeatt S, Southgate T, Perone MJ, Dewey R. Bolognani F, Morris I &Lowenstein PR 1999b Gene therapy using herpes simplex type 1 thymidine kinase (HSV1-TK) for the treatment of prolactin-secreting adenomas. Abstracts of the 81st Annual Meeting of the Endocrine Society (Abstract No. P2-P101) 302.
20. Chen J, Bezdek T, Chang J, Kherzai AW, Willingham T, Azzara M & Nisen PD 1998 A glial-specific, repressible, adenovirus vector for brain tumour gene therapy. Cancer Research 58 3504-3507.
21. Cosset F-L & Russell SJ 1996 Targeting retrovirus entry. Gene Therapy 3 946-956.
22. Csete ME, Benhamou PY, Drazan KE, Wu L, McIntee DF, Afra R, Mullen Y, Busuttil RW & Shaked A 1995 Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 59 263-268.
23. Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N & Verma IM 1995 Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proceeding of the National Academy of Sciences of the USA 92 1401-1405.
24. DeMatteo RP, McClane SJ, Fisher K, Yeh H, Chu G, Burke C & Raper SE 1997 Engineering tissue-specific expression of a recombinant adenovirus: selective transgene transcription in the pancreas using the amylase promoter. Journal of Surgical Research 72 155-161.
25. Dewey RA, Morrissey G, Cowsill CM, Stone D, Bolognani F, Dodd NJF, Southgate TD, Klatzmann D, Lassmann H, Castro MG & Lowenstein PR 1999 Chronic brain inflammation and persistent HSV1-TK expression in survivors of syngeneic glioma treatment by adenovirus-mediated gene therapy: implications for clinical trials. Nature Medicine 5 1256-1263.
26. Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N & Curiel DT 1998 An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilisation of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. Journal of Virology 72 9706-9713.
27. Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M & Curiel DT 1996 Targeted gene delivery by tropism-modified adenoviral vectors. Nature Biotechnology 14 1574-1578.
28. Duisit G, Salvetti A, Mouiller P & Cosset FL 1999 Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. Human Gene Therapy 20 189-200.
29. Englehardt JF, Litzky L & Wilson JM 1994a Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective for E2a. Human Gene Therapy 5 1217-1229.
30. Englehardt JF, Ye X, Doranz B & Wilson JM 1994b Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proceeding of the National Academy of Sciences of the USA 91 6196-6200.
31. Etienne-Julan M, Roux P, Carillo S.Jeanteur P & Piechaczyk M 1992 The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker. Journal of General Virology 73 3251-3255.
32. Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC & Van der Eb AJ 1996 Characterisation of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Human Gene Therapy 7 215-222.
33. Feng M, Jackson WH Jr, Goldman CK, Rancourt C, Wang M, Dusing SK, Siegal G & Curiel DT 1997 Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nature Biotechnology 15 866-870.
34. Fotaki ME, Pink JR & Mous J 1997 Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer. Gene Therapy 4 901-908.
35. Franz WM, Brem G, Katus HA, Klingel K, Hofschneider PH & Kandolf R 1994 Characterization of a cardiac-selective and developmentally upregulated promoter in transgenic mice. Cardioscience 5 235-243.
36. Freese A, During MJ, Davidson BL, Gennarelli TA, Kaplitt MG, Flamm ES & Snyder PJ 1996 Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release. Journal of Clinical Endocrinology and Metabolism 81 2401-2404.
37. Geddes BJ, Harding TC, Hughes DS, Byrnes AP, Lightman SL, Conde G & Uney JB 1997a Persistent transgene expression in the hypothalamus following stereotaxic delivery of a recombinant adenovirus: suppression of the immune response with cyclosporin. Endocrinology 137 5166-5169.
38. Geddes BJ, Harding TC, Lightman SL & Uney JB 1997b Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nature Medicine 3 1402-14044.
39. Geller Al, Yu L, Wang Y & Fraefel C 1997 Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders. Experimental Neurology 144 98-102.
40. van Ginkel FW, McGhee JR, Liu C, Simecka JW, Yamamoto M, Fnizzell RA, Sorscher EJ, Kiyono H & Pascual DW 1997 Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. Journal of Immunology 159 685-693.
41. Glorioso JC, Goins WF & Fink DJ 1992 Herpes simplex virus-based vectors. Seminars in Virology 3 428-432.
42. Gossen M & Bujard H 1992 Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences of the USA 89 5547-5551.
43. Goud B, Legrain P & Buttin G 1988 Antibody-mediated binding of a murine ecotropic moloney retroviral vector to human cells allows internalisation but not establishment of the pro-viral state. Virology 163 251-254.
44. Goya RG, Rowe J, Sosa YE, Tomasec P, Lowenstein PR & Castro MG 1998 Use of recombinant herpes simplex virus type 1 vectors for gene transfer into tumour and normal anterior pituitary cells. Molecular and Cellular Endocrinology 139 199-207.
45. Graham FL, Smiley J, Russell WC & Naim R 1977 Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36 59-72.
46. Graham FL & Prevec L 1991 Manipulation of adenovirus vectors. In Methods in Molecular Biology. Gene Transfer and Expression Techniques, vol 7, pp 109-128. Eds EJ Murray & JM Walker. Clifton: Humana Press.
47. Harding TC, Geddes BJ, Murphy D, Knight D & Uney JB 1998 Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system, Nature Biotechnology 16 553-555.
48. Hart IR & Vile RG 1995 Targeted gene therapy. British Medical Bulletin 51 647-655.
49. Haugen BR, McDermott MT, Gordon DF, Rupp CL, Wood WM & Ridgway EC 1996 Determinants of thyrotrope-specific thyrotropin beta promoter activation. Cooperation of Pit-1 with another factor. Journal of Biological Chemistry 271 385-389.
50. Horellou P, Guibert B, Lievel V & Mallet J 1989 Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proceedings of the National Academy of Sciences of the USA 86 7233-7237.
51. Huard J, Goins WF & Glorioso JC 1995 Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Therapy 2 385-392.
52. Hussain MA, Lee J, Miller CP & Habener JF 1997 POU domain transcription factor brain 4 confers pancreatic alpha-cell-specitic expression of the proglucagon gene through interaction with a novel proximal promoter G1 element. Molecular and Cellular Biology 17 7186-7194.
53. Hwang JJ, Scuric Z & Anderson WF 1996 Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. Journal of Virology 70 8138-8141.
54. Ivan M, Ludgate M, Gire V, Bond JA & Wyndford-Thomas D 1997 An amphotropic retroviral vector expressing a mutant gsp oncogene: effects on human thyroid cells in vitro. Journal of Clinical Endocrinology and Metabolism 82 2702-2709.
55. Ju Q, Edelstein D, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG & Brownlee M 1998 Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 41 736-739.
56. Kaner RJ, Baird A, Manusukhani A, Basilico C Summers BD, Florkiewicz RZ & Hajjar DP 1990 Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1. Science 248 1410-1413.
57. Kirn DH & McCormick F 1996 Replicating viruses as selective cancer therapeutics. Molecular Medicine Today 2 519-527.
58. Ko SC, Gotoh A, Thalmann GN, Zhatu HE, Johnston DA, Zhang WW, Kao C & Chung LW 1996 Molecular therapy with recombinant p53 adenovirus in an androgren-independent, metastatic human prostate cancer model. Human Gene Therapy 10 1683-1691.
59. Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S & Caskey CT 1996 A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proceedings of the National Academy of Sciences of the USA 93 5731-5736.
60. Korfhagen TR, Glasser SW, Wert SE, Bruno MD, Daugherty CC, McNeish JD, Stock JL, Potter SS & Whitsett JA 1990 Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice. Proceedings of the National Academy of Sciences of the USA 87 6122-6126.
61. Kotin KM & Berns KI 1989 Organization of adeno-associated virus DNA in latency infected Detroit 6 cells. Virology 170 460-467.
62. Krasnykh VN, Mikheeva GV, Douglas JT & Curiel DT 1996 Generation of rccombinant adenovirus vectors with modified fibers for altering viral tropism. Journal of Virology 70 6839-6846.
63. Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N & Curiel DT 1998 Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. Journal of Virology 72 1844-1852.
64. Kraus J, Buchfelder M & Hollt V 1993 Regulatory elements of the human proopiomelancortin gene promoter. DNA and Cell Biology 12 527-536.
65. Krisky DM, Wolfe D, Goins WF, Marconi PC, Ramakrishnan R, Mata M, Rouse RJ, Fink DJ & Glorioso JC 1998 Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Therapy b 1593-1603.
66. Laquerre S, Goins WF, Motiuchi S, Oligino TJ, Krisky DM, Marconi JC, Soares MK, Cohen JB, Glorioso JC & Fink DJ 1999 Gene-transfer tool: herpes simplex virus vectors. In The Development of Human Gene Therapy, pp 173-208. Ed T Friedman. New York: Cold Spring Harbor Laboratory Press.
67. Lazennec G & Katzenellenbogen BS 1999 Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells. Molecular and Cellular Endocrinology 25 93-105.
68. Lee EJ, Anderson LM, Thimmapaya B & Jameson JL 1999 Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumours. Journal of Clinical Endocrinology and Metabolism 84 786-794.
69. Leib DA & Olivo PD 1993 Gene delivery to neurons: is herpes simplex virus the right tool for the job? Bioessays 15 547-554.
70. Leibowitz G, Beattie GM, Kafri T, Cirulli V, Lopez AD, Hayek A & Levine F 1999 Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 48 745-753.
71. Leonard J, Peers H, Johnson T, Ferreri K, Lee S & Montminy MR 1993 Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Molecular Endocrinology 7 1275-1283.
72. Liu Y, Rabinovitch A, Suarez-Pinzon W, Muhkerjee B, Brownlee M, Edelstein D & Federoff HJ 1996 Expression of the bcl-2 gene from a defective HSV-I amplicon vector protects pancreatic beta-cells from apoptosis. Human Gene Therapy 7 1719-1726.
73. Lo WD, Qu G, Sferra TJ, Clark R, Chen R & Johnson PR 1999 Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Human Gene Therapy 10 201-213.
74. Lowenstein PR, Morrison EE. Bain D, Hodge P, Preston CM, Clissold P, Stow ND, McKee TA & Castro MG 1994 Use of recombinant vectors derived from herpes simplex virus 1 mutant tsK for short-term expression of transgenes encoding cytoplasmic and membrane anchored proteins in postmitotic polarized cortical neurons and glial cells in vitro. Neuroscience 60 1059-1077.
75. Lowenstein PR, Fournel S, Bain D, Tomasec P, Clissold PM, Castro MG & Epstein AL 1995 Simultaneous detection of amplicon and HSV-1 helper encoded proteins reveals that neurons and astrocytoma cells do express amplicon-borne transgenes in the absence of synthesis of virus immediate early proteins. Brain Research and Molecular Brain Research 30 169-175.
76. Lowenstein PK, Shering AF, Bain D, Castro MG & Wilkinson GWG 1996 The use of adenovirus vectors to transfer genes to identified target brain cells in vitro. In Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders, ch 8, pp 93-114. Eds PR Lowenstein & LW Enquist. London: John Wiley & Sons.
77. Lowenstein PR, Thomas CE & Castro MG 1999 Perspective. Politically correct gene therapy? A 'clean environment' improves gene delivery to the brain. Gene Therapy 6 463-464.
78. McClane SJ, Hamilton TE, Burke CV & Rasper SE 1997 Functional consequences of adenovirus-mediated murine pancreatic gene transfer. Human Gene Therapy 8 739-746.
79. McPhaul MJ, Deslypere JP, Allman DR & Gerard RD 1993 The adenovirus-mediated delivery of androgen receptor function in genital skin fibroblast cultures. Stimulation of Gs and inhibition of G(o). Journal of Biological Chemistry 268 26063-26066.
80. McPhaul MJ, Schweikert HU & Allman DR 1997 Assessment of androgen receptor function in genital skin fibroblasts using a recombinant adenovirus to deliver an androgen-responsive reporter gene. Journal of Clinical Endocrinology and Metabolism 82 1944-1948.
81. Matano T, Odawara T, Iwamoto A & Yoshikura H 1995 Targeted infection of retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1. Journal of Central Virology 76 3165-3169.
82. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD & Kandel ER 1996 Control of memory formation through regulated expression of a CaMKII transgene. Science 274 1678-1683.
83. Michael SI, Hong JS, Curiel DT & Engler JA 1995 Addition of a short peptide ligand to the adenovirus fiber protein. Gene Therapy 2 660-668.
84. Michou AI, Santoro L, Christ M, Julliard V, Pavirani A & Mehtali M 1997 Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression, Gene Therapy 4 473-482.
85. Miyanohara A, Johnson PA, Elam RL, Dai Y, Witztum JL & Verma IM 1992 Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX. New Biology 4 238-246.
86. Morelli AE, Larregina AT, Smith-Arica J, Dewey RA, Southgate TD, Ambar B, Fontana A, Castro MG & Lowenstein PR 1999 Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity. Journal of General Virology 3 571-578.
87. Morsy MA, Gu M, Motzel S, Zhao J, Lin J, Su Q, Allen H, Franlin L, Parks RJ, Graham FL, Kochanek S, BettAJ & Caskey CT 1998 An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proceedings of the National Academy of Sciences of the USA 95 7866-7877.
88. Murphy JE, Zhou S, Giese K, Williams LT, Escobedo JA & Dwarki VJ 1997 Long-term correction of obesity and diabetes in genetically obese mice by a single injection of recombinant adeno-associated virus encoding mouse leptin. Proceedings of the National Academy of Sciences of the USA 94 13921-13926.
89. Muzzin P, Eisensmith RC, Copeland KC & Woo SLC 1996 Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proceedings of the National Academy of Sciences of the USA 93 14804-14808.
90. Nakanishi M, Mizuguchi H, Ashihara K, Senda T, Eguchi A, Watabe A, Nakanishi T, Kondo M, Nakagawa T, Masago A, Okabe J, Ueda S, Mayumi T & Hayakawa T 1999 Gene delivery systems using the sendai virus. Molecular Membrane Biology 16 123-127.
91. Naldini L 1998 Lentiviruses as gene transfer agents for delivery to non-dividing cells. Current Opinions in Biotechnology 9 457-463.
92. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM & Trono D 1996 In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 263-267.
93. Naldini L, Blomer U, Gage FH, Trono D & Verma IM 1997 Efficient transfer, integration, and sustained long term expression of the transgene in adult rat brains injected with a lentiviral vector. Proceedings of the National Academy of Sciences of the USA 93 11382-11388.
94. Neill JD, Musgrove LC, Duck LW & Sellers JC 1999 High efficiency method for gene transfer in normal pituitary gonadotropes: adenoviral-rnediated expression of G protein-coupled receptor kinase 2 suppresses luteinising hormone secretion. Endocrinology 140 2562-2569.
95. Nilson BH, Morling FJ, Cosset F-L & Russell SJ 1996 Targeting of retroviral vectors through protease-substrate interactions. Gene Therapy 3 280-286.
96. O'Malley BW Jr & Ledley FD 1993 DNA- and viral-mediated gene transfer in follicular cells: progress toward gene therapy of the thyroid. Laryngoscope 103 1084-1092.
97. O'Malley BW Jr, Adams RM, Sikes ML, Sawada T & Ledley FD 1993 Retrovirus-mediated gene transfer into canine thyroid using an ex vivo strategy. Human Gene Therapy 4 171-178.
98. Palmer TD & Gage FH 1996 Delivery of gene products to the central nervous system by grafting retrovirally engineered neuronal and non-neuronal cells. In Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders, ch 8, pp 93-114. Eds PR Lowenstein & LW Enquist. London: John Wiley & Sons.
99. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA & Graham FL 1996 A helper-dependant adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proceedings o[ the National Academy of Sciences of the USA 93 13565-13570.
100. Peng K-W, Morling FJ, Cosset F-L, Murphy G & Russell SJ 1997 A gene delivery system activatable by disease-associated matrix metalloproteinases. Human Gene Therapy 8 729-738.
101. Peng K-W, Morling FJ, Cosset F-L & Russell SJ 1998 Retroviral gene delivery system activatable by plasmin. Tumour Targeting 3 112-120.
102. Peplinski GR, Tsung K & Norton JA 1998 Vaccinia virus for human gene therapy. Surgical Oncology Clinics of North America 7 575-588.
103. Polo JM, Belli BA, Driver DA, Frolov I, Sherrill S, Hariharan MJ, Townsend K, Perri S, Mento SJ, Jolly DJ, Chang SM, Schlesinger S & Dubensky TW Jr 1999 Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proceedings of the National Academy of Sciences of the USA 96 4598-4603.
104. Potter JJ, Cheneval D, Dang CV, Resar LM, Mezey E & Yang VW 1991 The upstream stimulatory factor binds to and activates the promoter of the rat class I alcohol dehydrogenase gene. Journal of Biological Chemistry 266 15457-15463.
105. Raper SE & DeMatteo RP 1996 Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas. Pancreas 12 401-410.
106. Reynolds PN, Feng M & Curiel DT 1999 Chimeric viral vectors -the best of both worlds? Molecular Medicine Today 5 25-31.
107. Richards CA, Austin EA & Huber BE 1995 Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Human Gene Therapy 6 881-893.
108. Riley DJ, Nikitin AY & Lee WH 1996 Adenovirus-mediated retinoblastoma gene therapy suppresses spontaneous pituitary melanotroph tumours in Rb + / - mice. Nature Medicine 2 1316-1321.
109. Ring CJ, Harns JD, Hurst HC & Lemoine NR 1996 Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter. Gene Therapy 3 1094-1103.
110. Rivera VM, Ye X, Courage NL, Sachar J, Cerasoli F Jr, Wilson JM & Gilman M 1999 Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proceedings of the National Academy of Sciences of the USA 96 8657-8662.
111. Robertson ES, Ooka T & Kieff ED 1996 Epstein-Barr virus vectors for gene delivery to B lymphocytes. Proceedings of the National Academy of Sciences of the USA 93 11334-11340.
112. Roe TY, Reynolds TC, Yu G & Brown PO 1993 Integration of murine leukaemia virus DNA depends on mitosis. EMBO Journal 12 2099-2108.
113. Rogers BE, Douglas JT, Ahlem C, Buchsbaum DJ, Frincke J & Curiel DT 1997 Use of a novel cross-linking method to modify adenovirus tropism. Gene Therapy 4 1387-1392.
114. Rose JA, Berns KI, Hoggan MD & Koczot FJ 1969 Evidence for a single-stranded adeno-associated virus genome: formation of a DNA density hybrid on release of viral DNA. Proceedings of the National Academy of Sciences of the USA 64 863-869.
115. Roux P, Jeanteur & Piechaczyk M 1989 A versatile approach to the targeting of specific cell types by retroviruses. Proceedings of the National Academy of Sciences of the USA 86 9079-9083.
116. Saeki Y, Ichikawa T, Saeki A, Chiocca EA, Tobler K, Ackermann M, Breakefield XO & Fraefel C 1998a Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Human Gene Therapy 10 2787-2794.
117. Saeki Y, Wataya-Kaneda M, Tanaka K & Kaneda Y 1998b Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes. Gene Therapy 5 1031-1037.
118. Samaniego LA, Niederhiser L & DeLuca NA 1998 Persistence and expression of a herpes simplex virus genome in the absence of immediate-early proteins. Virology 72 3307-3320.
119. Samulski RJ, Chang LS & Shenk T 1989 Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. Journal of Virology 63 3822-3828.
120. Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL & Kochanek S 1998 Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Genetics 18 180-183.
121. Shenk T 1996 Adenoviridae: the viruses and their replication. In Fundamental Virology, edn 3, pp 979-1016. Eds BN Fields, DM Knipe & PM Howley. Philadelphia: Lippincott-Raven Publishers.
122. Shering AF, Bain D, Stewart K, Epstein AL, Castro MG, Wilkinson GW & Lowenstein PR 1997 Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. Journal of General Virology 78 445-459.
123. Short DK, Okada S, Yamauchi K & Pessin JE 1998 Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice. American Journal of Physiology 275 E748-E756.
124. Sigalla J, David A, Anegon I, Fiche M, Huvelin JM, Boeffard F, Cassard A, Soulillou JP & Le Mauff B 1997 Adenovirus-mediated gene transfer into isolated mouse adult pancreatic islets: normal beta-cell function despite induction of an anti-adenovirus immune response. Human Gene Therapy 8 1625-1634.
125. Smith-Arica J, Stanley PJ, Windeatt S, Davis JRE, Smith J, Lowenstein PR & Castro MG 1999 Pituitary specific and inducible gene expression from first generation adenoviral vectors in vitro: possibilities tor gene therapy. Abstracts of the 2nd Annual Meeting of the American Society for Gene Therapy (Abstract No. 776) 196a.
126. Srivastava A, Lusby EW & Berns KI 1983 Nucleotide sequence and organisation of the adeno-associated virus 2 genome. Journal of Virology 45 555-564.
127. Sugiyama, Hattori S, Tanaka S, Isoda F, Kleopoulos S, Rosenfeld M, Kaplitt M, Sekihara H & Mobbs C 1997 Defective adeno-associated viral-mediated transtection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mouse. Hormone and Metabolism Research 28 599-603.
128. Summerford C & Samulski RJ 1998 Membrane-associated heparin sulphate proteoglycan is a receptor for adeno-associated virus type 2 virions. Journal of Virology 72 1438-1445.
129. Summerford C, Bartlett JS & Samulski RJ 1999 AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nature Medicine 5 78-82.
130. Thomas CE, Schneider G, Kochanek S, Castro MG & Lowenstein PR 1999 Adenovirus-mediated gene transfer to the brain: 'gutless' versus first generation vectors. Abstracts of the British Neuroscience Association. 15 no. 11·25.
131. Tsukamoto H, Wells D, Brown S, Serpente P, Strong P, Drew J, Inui K, Okada S & Dickson G 1999 Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice. Gene Therapy 6 1331-1335.
132. Valsesia-Wittmann S, Drynda A, Deleage G, Aumailley M, Heard JM, Danos O, Verdier G & Cosset FL 1994 Modifications of the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. Journal of Virology 68 4609-4619.
133. Wang M-Y, Koyama K, Shimabukuro M, Mangelsdorf D, Newgard CB & Unger RH 1997a Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2. glucokinase, and glucose-stimulated insulin secretion. Proceedings of the National Academy of Sciences of the USA 95 11921-11926.
134. Wang M-Y, Koyama K, Shimabukuro M, Newgard CB & Unger RH 1997b OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proceedings of the National Academy of Sciences of the USA 95 714-718.
135. Watkins SJ, Mesyanzhinov VV, Kurochkina LP & Hawkins RE 1997 The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery. Gene Therapy 4 1004-1012.
136. Weiss RA & Tailor CS 1995 Retrovirus receptors. Cell 82 531-533.
137. Wickham TJ, Mathias P, Cheresh DA & Nemerow GR 1993 Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73 309-319.
138. Wickham TJ, Carrion ME & Kovesdi I 1995 Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Therapy 2 750-756.
139. Wickham TJ, Roelvink PW, Brough DE & Kovesdi I 1996a Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nature Biotechnology 14 1570-1573.
140. Wickham TJ, Segal DM, Roelvink PW, Carrion ME, Lizonova A, Lee GM & Kovesdi I 1996b Targeted adenovirus gene transfer to endothelial and smooth muscle cells using bispecific antibodies. Journal of Virology 70 6831-6838.
141. Wickham TJ, Lee GM, Titus JA, Sconocchia G, Bakacs T, Kovesdi I & Segal DM 1997a Targeted adenovirus-mediated gene delivery to T cells via CD3 cells. Journal of Virology 71 7663-7669.
142. Wickham TJ, Tzeng E, Shears LLN, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A & Kovesdi I 1997b Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. Journal of Virology 71 8221-8229.
143. Wilkinson GWG, Darley RL & Lowenstein PR 1994 Viral vectors for gene therapy. In From Genetics to Gene Transfer, pp 161-193 Ed DS Latchman. Oxford: BIOS Scientific Publishers Ltd.
144. Windeatt S, Perone MJ, Davis JR, Lowenstein PR & Castro MG 1999a Development of a cell-type specific recombinant adenovirus for transgene expression in pituitary lactotrophic cells. Abstracts of the 81st Annual Meeting of the Endocrine Society (Abstract No. P2-100) 302.
145. Windeatt S, Perone M, Dewey R, Southgate T, Larregina A, Morris I, Lowenstein PR & Castro MG 1999b Gene therapy using herpes simplex type 1 thymidine kinase (HSV-1 TK) for the treatment of prolactin-secreting adenomas. Journal of Endocrinology 160 (Suppl) 152.
146. Wolf D, Richter-Landsberg C, Short MP, Cepko C & Breakefield XO 1988 Retrovirus-mediated gene transfer of beta-nerve growth factor into mouse pituitary line AtT-20. Molecular Biology and Medicine 5 43-59.
147. Worgall S, Wolff G, Falck-Pedersen E & Crystal RG 1997 Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Human Gene Therapy 8 37-44.
148. WuDunn D & Spear PG 1989 Initial interaction of herpes simplex virus with cells is binding to heparan sulphate, Journal of Virology 63 52-58.
149. Xiao X, Li J & Samulski KJ 1996 Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-asscxiated virus vector. Journal of Virology 70 8098-8108.
150. Xiao X, Li J & Samulski KJ 1998 Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. Journal of Virology 72 2224-2232.
151. Yang Y, Ertl HCJ & Wilson JM 1994a MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1 433-442.
152. Yang Y, Nunes FA, Berensi K, Furth EE, Gönczöl E & Wilson JM 1994b Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proceedings of the National Academy of Sciences of the USA 91 4407-4411.
153. Yang Y, Nunes FA, Berensi K, Gönczöl E, Engelhardt JF & Wilson JM 1994c Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genetics 7 362-369.
154. Yang Y, Li Q, Ertl HCJ & Wilson JM 1995 Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. Journal of Virology 69 2004-2015.
155. Yang Y, Jooss KU, Su Q, Ertl HC & Wilson JM 1996 Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Therapy 3 137-144.
156. Zhang R, Baunoch D & DeGroot LJ 1998a Genetic immunotherapy for medullary thyroid carcinoma: destruction of tumors in mice by in vivo delivery of adenoviral vector transducing the murine interleukin-2 gene. Thyroid 8 1137-1146.
157. Zhang R, Minemura K & De Groot LJ 1998b Immunotherapy for medullary thyroid carcinoma by a replication-defective adenovirus transducing murine interleukin-2. Endocrinology 139 601-608.
158. Zhang R, Straus FH & DeGroot LJ 1999 Effective genetic therapy of established medullary thyroid carcinomas with murine interleukin-2: dissemination and cytotoxicity studies in a rat tumor model. Endocrinology 140 2152-2158.